Under the proposed transaction, Lantheus investors are slated to receive $102.50 per share in cash. The deal also includes non-transferable contingent value rights, which could grant shareholders an additional $12.00 per share if specific commercial milestones for company products are met through 2030. Juan Monteverde, whose firm is recognized as a Top 50 entity in the 2025 ISS Securities Class Action Services Report, is spearheading the review to determine if the valuation reflects a fair price for current stakeholders. The firm is inviting shareholders to contact their offices to discuss the implications of the sale and their rights regarding the proposed merger.